Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study (2024)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1111/jdi.14079
- Subjects: COVID-19; DIABETES MELLITUS INSULINO-DEPENDENTE
- Language: Inglês
- Imprenta:
- Source:
- Título: JOURNAL OF DIABETES INVESTIGATION
- ISSN: 2040-1116
- Volume/Número/Paginação/Ano: v. 15, n. 1, Special Issue, p. 131-138, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CHATTERJEE, Tulika et al. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. JOURNAL OF DIABETES INVESTIGATION, v. 15, n. 1, p. 131-138, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57840. Acesso em: 28 fev. 2026. -
APA
Chatterjee, T., Ravichandran, N., Nair, N., Gracia-Ramos, A. E., Barman, B., Sen, P., et al. (2024). Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. JOURNAL OF DIABETES INVESTIGATION, 15( 1), 131-138. doi:10.1111/jdi.14079 -
NLM
Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, Saha S, Nune A, Pande AKR, Shinjo SK. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study [Internet]. JOURNAL OF DIABETES INVESTIGATION. 2024 ; 15( 1): 131-138.[citado 2026 fev. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57840 -
Vancouver
Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, Saha S, Nune A, Pande AKR, Shinjo SK. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study [Internet]. JOURNAL OF DIABETES INVESTIGATION. 2024 ; 15( 1): 131-138.[citado 2026 fev. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57840 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Informações sobre o DOI: 10.1111/jdi.14079 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
